Nanotechnology-Based Drug Delivery of Topical Antifungal Agents
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
Among the various prominent fungal infections, superficial ones are widespread. A large number of antifungal agents and their formulations for topical use are commercially available. They have some pharmacokinetic limitations which cannot be retracted by conventional delivery systems. While nanoformulations composed of lipidic and polymeric nanoparticles have the potential to overcome the limitations of conventional systems. The broad spectrum category of antifungals i.e. azoles (ketoconazole, voriconazole, econazole, miconazole, etc.) nanoparticles have been designed, prepared and their pharmacokinetic and pharmacodynamic profile was established. This review briefly elaborates on the types of nano-based topical drug delivery systems and portrays their advantages for researchers in the related field to benefit the available antifungal therapeutics.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
|---|---|
| Enthalten in: |
Pharmaceutical nanotechnology - (2023) vom: 18. Aug. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Singh, Sumita [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antifungal agents |
|---|
| Anmerkungen: |
Date Revised 18.08.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.2174/2211738511666230818125031 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM360929508 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM360929508 | ||
| 003 | DE-627 | ||
| 005 | 20231226084052.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/2211738511666230818125031 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1203.xml |
| 035 | |a (DE-627)NLM360929508 | ||
| 035 | |a (NLM)37594096 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Singh, Sumita |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Nanotechnology-Based Drug Delivery of Topical Antifungal Agents |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 18.08.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
| 520 | |a Among the various prominent fungal infections, superficial ones are widespread. A large number of antifungal agents and their formulations for topical use are commercially available. They have some pharmacokinetic limitations which cannot be retracted by conventional delivery systems. While nanoformulations composed of lipidic and polymeric nanoparticles have the potential to overcome the limitations of conventional systems. The broad spectrum category of antifungals i.e. azoles (ketoconazole, voriconazole, econazole, miconazole, etc.) nanoparticles have been designed, prepared and their pharmacokinetic and pharmacodynamic profile was established. This review briefly elaborates on the types of nano-based topical drug delivery systems and portrays their advantages for researchers in the related field to benefit the available antifungal therapeutics | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Antifungal agents | |
| 650 | 4 | |a Azoles | |
| 650 | 4 | |a Drug delivery systems | |
| 650 | 4 | |a Nanotechnology | |
| 650 | 4 | |a Topical agents | |
| 700 | 1 | |a Patil, Vaishali M |e verfasserin |4 aut | |
| 700 | 1 | |a Paliwal, Sarvesh Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Masand, Neeraj |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pharmaceutical nanotechnology |d 2016 |g (2023) vom: 18. Aug. |w (DE-627)NLM265590620 |x 2211-7393 |7 nnns |
| 773 | 1 | 8 | |g year:2023 |g day:18 |g month:08 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/2211738511666230818125031 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 18 |c 08 | ||